It is the internal testing website that you are visiting. Please go to our official customer website (www.myplaniq.com).
Find A Portfolio/Ticker
Comparison Box
DRGS: RBS Global Big Pharma ETN (ETF)
Basic Info
| Asset Class: | Health |
| MyPlanIQ Rating: | (100%) |
| Start Date: | 10/25/2011 |
| Last Dividend Date: | - |
| 12-Mo. Yield | 0.00% |
| Expenses | 0.60% |
| Sign up to get fund ranking change alerts | |
Performance Analytics (As of 01/28/2015)
Not up-to-date? Try| Last 1 Week* | 1 Yr | 3 Yr | Since 10/25/2011 |
2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|
| Annualized Return(%) | 0.5 | 30.5 | 27.9 | 28.2 | 4.3 | 25.4 | 44.2 | 11.4 | 6.7 |
| Sharpe Ratio | NA | 1.35 | 1.63 | 1.64 | 5.14 | 1.1 | 3.08 | 0.98 | 2.0 |
| Draw Down(%) | NA | 11.6 | 11.6 | 11.6 | 1.6 | 11.6 | 5.6 | 7.9 | 6.7 |
| Standard Deviation(%) | NA | 22.6 | 17.1 | 17.2 | 15.7 | 23.0 | 14.3 | 11.6 | 21.3 |
| Treynor Ratio | NA | 0.38 | 0.42 | 0.49 | 1.65 | 0.31 | 0.96 | 0.17 | 4.66 |
| Alpha | NA | 0.01 | 0.02 | 0.04 | 0.15 | 0.02 | 0.08 | 0.01 | 0.14 |
| Beta | NA | 0.8 | 0.67 | 0.58 | 0.49 | 0.83 | 0.46 | 0.66 | 0.09 |
| RSquared | NA | 0.21 | 0.2 | 0.16 | 0.19 | 0.22 | 0.11 | 0.32 | 0.01 |
| Yield(%) | N/A | 0.0 | 0.0 | N/A | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Dividend Growth(%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
*: NOT annualized;YTD: Year to Date
**Inception: starting from 10/25/2011
Calculate Performance
Start date (MM/dd/yyyy)
End date (MM/dd/yyyy)
|
View Historical Data in an advanced chart |
Use MyPlanIQ Comparison to compare with multiple funds or portfolios |
See Health Asset Class Trend Rankings |
Top Rated Funds in Health
Best Mutual Funds
- VGHCX (VANGUARD HEALTH CARE FUND INVESTOR SHARES) (97%)
- HGHAX (THE HARTFORD HEALTHCARE FUND CLASS A) (79%)
- FSMEX (MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO MEDICAL EQUIPMENT AND SYSTEMS PORTFOLIO) (78%)
- FBIOX (BIOTECHNOLOGY PORTFOLIO BIOTECHNOLOGY PORTFOLIO) (77%)
- FBTIX (FIDELITY ADVISOR BIOTECHNOLOGY FUND CLASS I) (77%)
- FPHAX (PHARMACEUTICALS PORTFOLIO PHARMACEUTICALS PORTFOLIO) (75%)
- FSHCX (HEALTH CARE SERVICES PORTFOLIO HEALTH CARE SERVICES PORTFOLIO) (74%)
- FSPHX (HEALTH CARE PORTFOLIO HEALTH CARE PORTFOLIO) (74%)
- FHCIX (FIDELITY ADVISOR HEALTH CARE FUND CLASS I) (73%)
- SHSSX (BLACKROCK HEALTH SCIENCES OPPORTUNITIES PORTFOLIO INSTITUTIONAL) (66%)
Best ETFs
- DRGS (RBS Global Big Pharma ETN) (100%)
- XLV (Health Care Select Sector SPDR Fund) (96%)
- BBH (VanEck Biotech ETF) (94%)
- IBB (iShares Biotechnology ETF) (94%)
- PPH (VanEck Pharmaceutical ETF) (94%)
- FBT (First Trust NYSE Arca Biotechnology Index Fund) (91%)
- FXH (First Trust Health Care AlphaDEX Fund) (90%)
- IHE (iShares U.S. Pharmaceuticals ETF) (88%)
- IHF (iShares U.S. Healthcare Providers ETF) (88%)
- IHI (iShares U.S. Medical Devices ETF) (88%)
Best Closed End Funds
- BME (BlackRock Health Sciences Trust) (100%)
- GRX (Gabelli Healthcare & WellnessRx Trust) (99%)
- HQH (Tekla Healthcare Investors) (98%)
- HQL (Tekla Life Sciences Investors) (98%)
